Prior authorization for Ozempic can be straightforward if you submit the right documentation upfront. This guide covers exactly what insurers look for and how to increase your chances of first-pass approval.
Typical Prior Authorization Requirements
Most insurers require:
- Diagnosis: Type 2 diabetes mellitus (ICD-10: E11.x)
- Current HbA1c: Above target (typically >7.0%)
- Prior therapy: Documentation of metformin trial (or contraindication)
- Prescriber: Must be or include recommendation from endocrinologist/PCP
- Dosing: Start at 0.25mg weekly, escalate per label
Documentation Checklist
- [ ] Current HbA1c (within last 3 months)
- [ ] Fasting glucose levels
- [ ] List of current diabetes medications with dates
- [ ] Prior metformin use (dates, dose, reason for discontinuation if applicable)
- [ ] BMI
- [ ] Statement of medical necessity from prescriber
Common PA Pitfalls
- Missing lab values — always include recent HbA1c
- Not documenting metformin trial — even if it was years ago
- Wrong diagnosis code — ensure E11.x (type 2), not E10.x (type 1)
- Incomplete prescriber information — NPI number, specialty
If Denied
- Request specific reason and clinical criteria used
- Schedule peer-to-peer review with insurer's medical director
- File formal appeal within 180 days
- Include any missing documentation identified in the denial